Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Scott Reeder
University of Wisconsin Madison, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Reveal Pharmaceuticals
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
An outside activity has a nexus with an individual's research activities if the outside activity arises from, relies upon or is related to the academic expertise that qualifies that individual to participate in federally funded research or human subjects research. The Institution has reasonably determined that the significant financial interest could directly and significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD
PUBLIC HEALTH RELEVANCE STATEMENT: The broad, long-term objective of our research is to improve the health of the nearly 100 million Americans with or at risk for non-alcoholic fatty liver disease. This disease can progress to liver failure, liver cancer, and liver-related death. We seek to develop and validate imaging methods that can diagnose this disease and determine its severity without a biopsy. Such methods will reduce the need for biopsy, permit earlier diagnosis, and facilitate more effective treatment, thereby preventing its long-term complications.
Filed on September 25, 2017.
Tell us what you know about Scott Reeder's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Scott Reeder filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Elucent | $80,000 - $99,999 |
| Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Elucent | $80,000 - $99,999 |
| Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Reveal Pharmaceuticals | $20,000 - $39,999 |
| Scott B. Reeder | University of Wisconsin Madison | Conflict of Interest | Neuwave Inc. | $20,000 - $39,999 |
| Scott B. Reeder | University of Wisconsin Madison | Conflict of Interest | Neuwave Inc. | $20,000 - $39,999 |
| Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Calimetrix | $0 - $4,999 |
| Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Calimetrix | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.